TAK242, a TLR4 antagonist, exerts a neuroprotective effect after cerebral ischemia-reperfusion injury.[27] As shown in our study, vinpocetine also inhibited TLR4 expression to attenuate the excessive and uncontrolled inflammatory response after cerebral ischemia-reperfusion injury. Here, TLR4 is linked to Cerebral ischemia.